ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New Wolters Kluwer tools help medical researchers accelerate the path to publication

Enhancements to the Lippincott platform streamline author workflow and expedite vital research dissemination

The path to publication for medical researchers can be a long process, in which scholars seek to maximize the profile of their research with global accessibility, increased downloads, and higher citations. To help broaden readership and amplify authors’ influence within the health research community, Wolters Kluwer Health announces the introduction of Lippincott Author Portal and Journal Recommender, key tools to boost the effectiveness and reach of new research.

“For medical researchers, the critical task of finding a home for their work is frequently slowed by the inefficiencies of journal selection and intricate author guidelines, leading to significant frustration,” said Rafael Sidi, Senior Vice President & General Manager of Health Research, Wolters Kluwer Health. “We are dedicated to removing these barriers, streamlining the publication process in prestigious journals to enhance author productivity and expedite the global dissemination of critical scientific insights.”

Streamlining and simplifying the medical research publishing journey

With the introduction of the Lippincott Author Portal, researchers and authors now have the tools they need to refine manuscripts, simplify submission procedures and accelerate time-to-publish. New features such as manuscript assistance and publishing process guidance, give researchers more control over their own path to publication, allowing them to focus on improving the reach of global health knowledge. The platform also features post-publication promotion tools, such as infographics and videos, to make it easier to increase visibility of new research.

“Finding the right journal in which to publish your paper can be challenging and time consuming – success in publishing with the first journal to which you submit your paper will get your work read more quickly and mean that you can proceed with your research rather than rewriting, reformatting and sometimes trying several journals before your work is finally published. These new, easy to use and very informative author resources provide helpful tools to assist in making sure that your paper is clear, help to find the right journal efficiently, and help to transit the path to publication in the most efficient and effective way,” said Joanna Wardlaw CBE, MB ChB (Hons), MD, FRCR, FRCP, FMedSci, FRSE, Professor of Applied Neuroimaging at the University of Edinburgh.

AI matches medical authors with the appropriate journal

The Wolters Kluwer Journal Recommender employs advanced AI machine learning algorithms to precisely match research with the most suitable journals, to optimize the submission process with fewer false starts and rejections. Its extensive search capabilities increase the likelihood of acceptance by thoroughly analyzing abstracts, complete manuscripts, keywords and relevant topics. Additionally, the tool provides essential information for each journal, including Impact Factor and indexing, so authors can feel comfortable with their choice.

To further support researchers in preparing journal-ready manuscripts, Wolters Kluwer offers a growing suite of professional editing services tailored to meet diverse author needs. This specialized support can range from standard grammar and language editing to translations for non-English speakers, or customized support for research promotion.

The Lippincott portfolio of publications boasts an esteemed collection of nearly 400 indexed titles and provides unparalleled visibility and credibility for healthcare researchers and practitioners worldwide. With a growing number of open access journals in the collection, authors benefit from broader reach, increased downloads, and higher citation rates—amplifying the impact of their work.

For more information about Wolters Kluwer, please visit: www.wolterskluwer.com

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.